SEOUL, May 13 (Korea Bizwire) — South Korea’s Lotte Group decided Friday to buy U.S. drug firm Bristol Myers Squibb (BMS)’s pharmaceutical factory in Syracuse, New York, for $160 million. Lotte’s board of directors approved the deal, which also includes BMS’s contract manufacturing agreements to produce medicine worth $220 million over the next three years. [...]
SEOUL, Jan. 26 (Korea Bizwire) — SK Biotek Co., the pharmaceutical unit of South Korean energy and telecom conglomerate SK Group, said Friday it has held an opening ceremony for its plant in Ireland, the latest attempt to expand its presence in the global market. SK Biotek purchased the plant in Swords from New York-based [...]
NEW YORK & SEOUL, South Korea, Apr. 22, 2014 (Korea Bizwire) – Bristol-Myers Squibb Company (NYSE:BMY) and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. Financial terms of the [...]